Where and how to find yield has become a common theme for heavyweight investors Carl Icahn, David Tepper and Jeff Gundlach.
The full CNBC interview with Carl Icahn.
When you find someone who's got a track record of actually delivering alpha, it's worth a listen.
The word of the day was "danger." And Donald Trump got a few shoutouts, not all of them kind.
Billionaire investor Carl Icahn discusses Herbalife, his feelings about presidential candidate Donald Trump and Herblife foe, Bill Ackman.
Billionaire investor Carl Icahn discusses Pershing Square's Bill Ackman and his long position on Herbalife at the Delivering Alpha conference with CNBC's Scott Wapner.
Consumer opinions of Chipotle Mexican Grill have slid in recent weeks on food safety concerns, a pollster said on Wednesday.
With shares of Chipotle down 42 percent from their 52-week high, Bill Ackman's appeal for organizational change may not be able to move the needle.
Jim Cramer says history is on Bill Ackman’s side, and lays out the price to stay hungry for Chipotle’s stock.
CNBC's Kate Kelly recaps Pershing Square Bill Ackman's tough year, and discusses his hunt for new opportunities.
The "Fast Money Halftime Report" traders discuss the trade on Chipotle amid news of Pershing Square's Bill Ackman acquiring a 9.9 percent stake in the restaurant chain.
Some of the names on the move ahead of the open.
Bill Ackman left the board of Canadian Pacific, marking the end of a four-year tenure that helped overhaul the ailing railroad company.
Chipotle Mexican Grill has already seen its worst days, Chipotle CFO John Hartung said in April.
Bill Ackman's Pershing Square just disclosed a 9.9 percent stake in Chipotle Mexican Grill, a stock that is down 42 percent in the past year.
Stephen Anderson, Maxim Group senior restaurant analyst, shares his take on Chipotle following news of Pershing Square Bill Ackman acquiring a 9.9 percent stake. The "Fast Money" traders weigh in.
Billionaire Carl Icahn bought 306,846 more shares of Herbalife on Aug. 31, according to a Friday filing.
The billionaire investor's portfolios were boosted by strong gains at drug company Valeant Pharmaceuticals.
Billionaire investor Carl Icahn rejected any assertion Tuesday that he is backed into a corner on troubled nutritional supplement company Herbalife.
The “Fast Money Halftime Report” traders and CNBC’s Jim Cramer share their take on Herbalife, as well as the company's release of new videos taking aim at Bill Ackman, Pershing Square Capital Management CEO.